Maren Schubert

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

Natalia Sherina, Antonio Piralla, Likun Du et al. · Med · 2021 · 196 citations · Full text

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

Fanglei Zuo, Hassan Abolhassani, Likun Du et al. · Nature Communications · 2022 · 161 citations · Full text

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

Federico Bertoglio, Viola Fühner, Maximilian Ruschig et al. · Cell Reports · 2021 · 103 citations · Full text

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Federico Bertoglio, Doris Meier, Nora Langreder et al. · Nature Communications · 2021 · 96 citations · Full text

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Maren Schubert, Federico Bertoglio, Stephan Steinke et al. · BMC Medicine · 2022 · 85 citations · Full text